Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis model of rheumatoid arthritis

Arthritis and Rheumatism

Volumn 62, Issue 11, 2010, Pages 3289-3299

  Abreu, Joana R F ^a   Krausz, Sarah ^a   Dontje, Wendy ^a   Grabiec, Aleksander M ^a   De Launay, Daphne ^a   Nolte, Martijn A ^a   Tak, Paul P ^a   Reedquist, Kris A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; COLLAGEN; COLLAGEN ANTIBODY; IMMUNOGLOBULIN; RAP1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HOMEOSTASIS; JOINT DESTRUCTION; MORBIDITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; T LYMPHOCYTE; TH17 CELL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RAP1 GTP-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 78249242763     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27656     Document Type: Article

References (44)

1. Lundy SK, Sarkar S, Tesmer LA, Fox DA,. Cells of the synovium in rheumatoid arthritis T lymphocytes. Arthritis Res Ther 2007; 9: 202.
2. Gourraud PA, Boyer JF, Barnetche T, Abbal M, Cambon-Thomsen A, Cantagrel A, et al. New classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum 2006; 54: 593 - 9.
3. Clark J, Vagenas P, Panesar M, Cope AP,. What does tumour necrosis factor excess do to the immune system long term? Ann Rheum Dis 2005; 64 Suppl 4: iv70 - 6.
4. Abreu JR, Grabiec AM, Krausz S, Spijker R, Burakowski T, Maslinski W, et al. The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling. J Immunol 2009; 183: 621 - 30.
5. dim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood 2007; 109: 4328 - 35.
6. Sattler A, Wagner U, Rossol M, Sieper J, Wu P, Krause A, et al. Cytokine-induced human IFN-γ-secreting effector-memory Th cells in chronic autoimmune inflammation. Blood 2009; 113: 1948 - 56.
7. Remans PH, Gringhuis SI, van Laar JM, Sanders ME, Papendrecht-van der Voort EA, Zwartkruis FJ, et al. Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. J Immunol 2004; 173: 920 - 31.
8. Remans PH, Wijbrandts CA, Sanders ME, Toes RE, Breedveld FC, Tak PP, et al. CTLA-4Ig suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPase mediator of oxidative stress in rheumatoid arthritis T cells. Arthritis Rheum 2006; 54: 3135 - 43.
9. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM,. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 1997; 278: 124 - 8.
10. Reedquist KA, Bos JL,. Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes. J Biol Chem 1998; 273: 4944 - 9.
11. Carey KD, Dillon TJ, Schmitt JM, Baird AM, Holdorf AD, Straus DB, et al. CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol Cell Biol 2000; 20: 8409 - 19.
12. Dillon TJ, Carey KD, Wetzel SA, Parker DC, Stork PJ,. Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4. Mol Cell Biol 2005; 25: 4117 - 28.
13. Schneider H, Valk E, da Rocha DS, Wei B, Rudd CE,. CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc Natl Acad Sci U S A 2005; 102: 12861 - 6.
14. Kinashi T, Katagiri K,. Regulation of lymphocyte adhesion and migration by the small GTPase Rap1 and its effector molecule, RAPL. Immunol Lett 2004; 93: 1 - 5.
15. Ishida D, Yang H, Masuda K, Uesugi K, Kawamoto H, Hattori M, et al. Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice. Proc Natl Acad Sci U S A 2003; 100: 10919 - 24.
16. + regulatory T cells in vivo. J Immunol 2005; 175: 3133 - 9.
17. Dillon TJ, Carey KD, Wetzel SA, Parker DC, Stork PJ,. Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4. Mol Cell Biol 2005; 25: 4117 - 28.
18. Duchniewicz M, Zemojtel T, Kolanczyk M, Grossmann S, Scheele JS, Zwartkruis FJ,. Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion. Mol Cell Biol 2006; 26: 643 - 53.
19. Li Y, Yan J, De P, Chang HC, Yamauchi A, Christopherson KW II, et al. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol 2007; 179: 8322 - 31.
20. Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA,. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat Immunol 2002; 3: 251 - 8.
21. Van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJ, Plater-Zyberk C, Vervoordeldonk MJ, et al. Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 2004; 6: R239 - 49.
22. Brinkmann T, Daumke O, Herbrand U, Kuhlmann D, Stege P, Ahmadian MR, et al. Rap-specific GTPase activating protein follows an alternative mechanism. J Biol Chem 2002; 277: 12525 - 31.
23. + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6. J Immunol 2008; 180: 7112 - 6.
24. Reinhardt RL, Liang HE, Locksley RM,. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol 2009; 10: 385 - 93.
25. Thomas R, Turner M, Cope AP,. High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis? Arthritis Res Ther 2008; 10: 210.
26. Maurice MM, Lankester AC, Bezemer AC, Geertsma MF, Tak PP, Breedveld FC, et al. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 1997; 159: 2973 - 8.
27. Gringhuis SI, Leow A, Papendrecht-van der Voort EA, Remans PH, Breedveld FC, Verweij CL,. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 2000; 164: 2170 - 9.
28. Gringhuis SI, Papendrecht-van der Voort EA, Leow A, Nivine Levarht EW, Breedveld FC, Verweij CL,. Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol Cell Biol 2002; 22: 400 - 11.
29. + T cells in vitro and in vivo. J Immunol 2007; 179: 8026 - 34.
30. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, et al. ICOS is critical for CD40-mediated antibody class switching. Nature 2001; 409: 102 - 5.
31. Iwai H, Kozono Y, Hirose S, Akiba H, Yagita H, Okumura K, et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 2002; 169: 4332 - 9.
32. Nurieva RI, Treuting P, Duong J, Flavell RA, Dong C,. Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest 2003; 111: 701 - 6.
33. Hu YL, Metz DP, Chung J, Siu G, Zhang M,. B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells. J Immunol 2009; 182: 1421 - 8.
34. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ,. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993; 261: 1328 - 30.
35. Ruth JH, Rottman JB, Kingsbury GA, Coyle AJ, Haines GK III, Pope RM, et al. ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis. Cytometry A 2007; 71: 317 - 26.
36. Gonzalo JA, Delaney T, Corcoran J, Goodearl A, Gutierrez-Ramos JC, Coyle AJ,. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation. J Immunol 2001; 166: 1 - 5.
37. MacDonald KP, Nishioka Y, Lipsky PE, Thomas R,. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997; 100: 2404 - 14.
38. Katagiri K, Hattori M, Minato N, Kinashi T,. Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses. Mol Cell Biol 2002; 22: 1001 - 15.
39. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R,. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003; 77: 4911 - 27.
40. Fuller MJ, Khanolkar A, Tebo AE, Zajac AJ,. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J Immunol 2004; 172: 4204 - 14.
41. Cho CS, Cho ML, Min SY, Kim WU, Min DJ, Lee SS, et al. CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor. J Immunol 2000; 164: 5055 - 61.
42. Foey AD, Feldmann M, Brennan FM,. CD40 ligation induces macrophage IL-10 and TNF-α production: differential use of the PI3K and p42/44 MAPK-pathways. Cytokine 2001; 16: 131 - 42.
43. Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M,. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor -B pathways in tumor necrosis factor α production in rheumatoid arthritis. Arthritis Rheum 2002; 46: 31 - 41.
44. Genovese MC, Schiff M, Luggen M, Becker JC, Aranda R, Teng J, et al. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Ann Rheum Dis 2008; 67: 547 - 54.